These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 7630430)

  • 1. Hypertrophic cardiomyopathy: a desensitized cardiac beta-adrenergic system in the presence of normal plasma catecholamine concentrations.
    Schumacher C; Becker H; Conrads R; Schotten U; Pott S; Kellinghaus M; Sigmund M; Schöndube F; Preusse C; Schulte HD
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):398-407. PubMed ID: 7630430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
    Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
    Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between beta-adrenoceptors and calcium channels in human ventricular myocardium.
    Ferry DR; Kaumann AJ
    Br J Pharmacol; 1987 Mar; 90(3):447-57. PubMed ID: 2436700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subsensitivity of the failing human heart to isoprenaline and milrinone is related to beta-adrenoceptor downregulation.
    Böhm M; Diet F; Feiler G; Kemkes B; Kreuzer E; Weinhold C; Erdmann E
    J Cardiovasc Pharmacol; 1988 Dec; 12(6):726-32. PubMed ID: 2467092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in cardiac beta-adrenoceptors in human heart diseases: relationship to the degree of heart failure and further evidence for etiology-related regulation of beta 1 and beta 2 subtypes.
    Steinfath M; Lavicky J; Schmitz W; Scholz H; Döring V; Kalmár P
    J Cardiothorac Vasc Anesth; 1993 Dec; 7(6):668-73. PubMed ID: 7905755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy characterised by beta-adrenoceptor density, relative amount of beta-adrenoceptor subtypes and adenylate cyclase activity.
    Golf S; Myhre E; Abdelnoor M; Andersen D; Hansson V
    Cardiovasc Res; 1985 Nov; 19(11):693-9. PubMed ID: 3000595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence against spare or uncoupled beta-adrenoceptors in the human heart.
    Schwinger RH; Böhm M; Erdmann E
    Am Heart J; 1990 Apr; 119(4):899-904. PubMed ID: 1969707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte beta 2-adrenoceptors mirror precisely beta 2-adrenoceptor, but poorly beta 1-adrenoceptor changes in the human heart.
    Michel MC; Beckeringh JJ; Ikezono K; Kretsch R; Brodde OE
    J Hypertens Suppl; 1986 Dec; 4(6):S215-8. PubMed ID: 2886571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic pindolol treatment on human myocardial beta 1- and beta 2-adrenoceptor function.
    Bjørnerheim R; Golf S; Hansson V
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):429-35. PubMed ID: 2175014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.
    Bjørnerheim R; Golf S; Hansson V
    Cardiovasc Res; 1991 Sep; 25(9):764-73. PubMed ID: 1666020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On minimum cyclic AMP formation rates associated with positive inotropic effects mediated through beta 1-adrenoceptors in kitten myocardium. Beta 1-specific and non-adrenergic stimulant effects of denopamine.
    Lemoine H; Teng KJ; Slee SJ; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):113-28. PubMed ID: 2566921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium.
    Böhm M; Beuckelmann D; Brown L; Feiler G; Lorenz B; Näbauer M; Kemkes B; Erdmann E
    Eur Heart J; 1988 Aug; 9(8):844-52. PubMed ID: 2460351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-adrenoceptors and alpha-adrenoceptor-mediated positive inotropic effects in failing human myocardium.
    Böhm M; Diet F; Feiler G; Kemkes B; Erdmann E
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):357-64. PubMed ID: 2464110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial beta-adrenoceptor density and the distribution of beta 1- and beta 2-adrenoceptor subpopulations in children with congenital heart disease.
    Kozlik R; Kramer HH; Wicht H; Krian A; Ostermeyer J; Reinhardt D
    Eur J Pediatr; 1991 Apr; 150(6):388-94. PubMed ID: 1645667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of beta-adrenergic signaling in compensated human cardiac hypertrophy depend on the underlying disease.
    Schotten U; Filzmaier K; Borghardt B; Kulka S; Schoendube F; Schumacher C; Hanrath P
    Am J Physiol Heart Circ Physiol; 2000 Jun; 278(6):H2076-83. PubMed ID: 10843907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
    von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete reversal of beta-adrenoceptor desensitization in human and guinea-pig cardiomyocytes by cyclic nucleotide phosphodiesterase inhibitors.
    Wynne DG; Poole-Wilson PA; Harding SE
    Br J Pharmacol; 1993 Aug; 109(4):1071-8. PubMed ID: 7691363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
    Böhm M; Mittmann C; Schwinger RH; Erdmann E
    Am Heart J; 1990 Dec; 120(6 Pt 1):1381-92. PubMed ID: 1978979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of cardiac glycosides in human myocardium with and without "downregulated" beta-adrenoceptors.
    Schwinger RH; Böhm M; Erdmann E
    J Cardiovasc Pharmacol; 1990 May; 15(5):692-7. PubMed ID: 1692927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (-)-Adrenaline elicits positive inotropic, lusitropic, and biochemical effects through beta2 -adrenoceptors in human atrial myocardium from nonfailing and failing hearts, consistent with Gs coupling but not with Gi coupling.
    Molenaar P; Savarimuthu SM; Sarsero D; Chen L; Semmler AB; Carle A; Yang I; Bartel S; Vetter D; Beyerdörfer I; Krause EG; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Mar; 375(1):11-28. PubMed ID: 17295024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.